From Numbers to Narrative: Mastering the Art of PK Presentation Guide From Numbers to Narrative: Mastering the Art of PK Presentation Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…Certara2026 年 3 月 20 日
Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Guide Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…Certara2026 年 3 月 19 日
Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026 Blog 通过模型引导的药物开发促进药物公平:ASCPT 2026 见解 Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…Certara2026 年 3 月 11 日
Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers Webinar Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers Certara2026 年 3 月 9 日
Navigate GxP Compliance in the Cloud with Confidence Guide Navigate GxP Compliance in the Cloud with Confidence Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…Certara2026 年 3 月 6 日
ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success Blog ADC 首次人体(FIH)剂量选择:成功设计 FIH 研究的关键 Optimize ADC First-in-Human Dose Selection with model-informed strategies and exposure–response insights to design safer, more…Certara2026 年 3 月 3 日
Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development Conference Apotekarsocieteten 临床药理学策略在药物开发中的应用 Danielle Pillsbury2026 年 3 月 2 日
Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) On-Demand Webinar Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit) This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…Certara2026 年 2 月 27 日